This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
BioLegend
other brands :
Babco, Signet, Sternberger Monoclonals, Senetek, Covance
product type :
antibody
product name :
LEAF™ Purified anti-human/mouse integrin β7
catalog :
321218
quantity :
500 μg
price :
290 USD
clonality :
monoclonal
host :
rat
conjugate :
nonconjugated
clone name :
FIB504
reactivity :
human, mouse, chimpanzee, rhesus macaque
application :
neutralization, flow cytometry
citations: 11
| Published Application/Species/Sample/Dilution | Reference |
|---|---|
| |
| |
Ohmori K, Luo Y, Jia Y, Nishida J, Wang Z, Bunting K, et al. IL-3 induces basophil expansion in vivo by directing granulocyte-monocyte progenitors to differentiate into basophil lineage-restricted progenitors in the bone marrow and by increasing the number of basophil/mast cell progenitors in the spleen. J Immunol. 2009;182:2835-41 pubmed publisher
|
product information
Antigen :
Integrin beta7
Apps. Abbrev. :
Flow Cytometry, Block
Cat # :
321218
Clone :
FIB504
Item :
LEAF™ Purified anti-human/mouse integrin β7
Isotype :
Rat IgG2a, κ
Other Names :
β7 Integrin, integrin βp, ITGB7
Size :
500 μg
Price (USD) :
290 USD
Reactivity :
Human, African Green, Baboon, Chimpanzee, Cynomolgus, Mouse, Rhesus
Clonality :
Monoclonal
Host :
Rat
Conjugate/Tag/Label :
LEAF
Immunogen :
TK1 cells
Application Notes :
The FIB504 antibody has been reported to react with mouse and human β7 integrin and to block β7 integrin-mediated cell adhesion in in vitro and in vivo studies. Additional reported applications (for the relevant formats) include: blocking of cell adhesion 1,3,4 . The Ultra-LEAF™ purified FIB504 antibody (Endotoxin 0.01 EU/μg, Azide-Free, 0.2 μm filtered) is recommended for functional assays (Cat. No. 321233-321238).
company information

BioLegend
8999 BioLegend Way
San Diego, CA 92121
San Diego, CA 92121
customerserv@biolegend.com
https://www.biolegend.comheadquarters: USA
questions and comments
